Amylase Quantitative Testing Drug
Vietnam·Risk Class TBYT Loại B·Amylase2·Abbott Ireland Diagnostics Division·Registered Oct 30, 2024- Analysis ID
- 240002953/PCBB-HN
- Submission ID
- 000.00.19.H26-241015-0003
- Product Type
- Amylase2
- Manufacturer
- Abbott Ireland Diagnostics Division
- Authorized Representative
- VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI
- Intended Use
- Amylase2 testing is used to quantify amylase in human serum, plasma, or urine on the ARCHITECT c Systems. Amylase2 testing is primarily used to support the diagnosis and treatment of pancreatitis (inflammation of the pancreas).
- Registration Date
- Oct 30, 2024
Companies providing products similar to "Amylase Quantitative Testing Drug"
Recently registered similar products
Access comprehensive regulatory information for Amylase Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TBYT Loại B medical device is registered under number 240002953/PCBB-HN and manufactured by Abbott Ireland Diagnostics Division. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI.
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Abbott Ireland Diagnostics Division, and 2 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.